Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > In the process
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(91)
•••
Comment by RockLobster1on Oct 14, 2020 10:11pm
213 Views
Post# 31719082

RE:RE:In the process

RE:RE:In the process
we are definitely being hit by the fast money that jumped in and are now baling out... fair enough.

On the chart we are sitting on the 200 days EMA at 4.65... and filling the gap that happened on the day we exploded to $9 in July....  Very oversold as well so i think we are near term bottomming.

Then we can get back to being a cancer vaccine company with a covid kicker.... IMO

I think for longer term from here to $4 is a great place to buy in...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities